Research Article
New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients
Table 3
HbA1c, PWv, and LVMI values of patients according to NODAT treatment modalities.
| ||||||||||||||||||||||||||||||||||||||||||
* value for LVMI between patients without NODAT and patients with NODAT under insulin therapy. |